Callahan Advisors’s Natus Medical Inc NTUS Stock Holding History

Callahan Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,935	Closed	-$227K	–	127
2017 Q4	$227K	Buy	5,935 +310	+6%	+$12.4K	0.05%	116
2017 Q3	$211K	Sell	5,625 -2,565	-31%	-$90.5K	0.04%	118
2017 Q2	$305K	Sell	8,190 -9,930	-55%	-$359K	0.07%	105
2017 Q1	$711K	Sell	18,120 -16,170	-47%	-$607K	0.16%	85
2016 Q4	$1.19M	Buy	34,290 +5,040	+17%	+$198K	0.29%	73
2016 Q3	$1.15M	Buy	29,250 +6,835	+30%	+$273K	0.29%	68
2016 Q2	$847K	Buy	22,415 +3,795	+20%	+$127K	0.22%	73
2016 Q1	$716K	Buy	18,620 +5,760	+45%	+$215K	0.2%	76
2015 Q4	$618K	Buy	12,860 +1,305	+11%	+$60.4K	0.18%	84
2015 Q3	$456K	Buy	+11,555	New	+$491K	0.14%	89

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

VCM

Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

Callahan Advisors's NTUS Position: Q1 2018 in Review

Callahan Advisors sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 5,935 shares — an estimated $227K sold.

Callahan Advisors first reported a position in NTUS in Q3 2015 and held it in 10 quarters. The position peaked at $1.19M in Q4 2016. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

Callahan Advisors reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
Callahan Advisors sold 5,935 Natus Medical Inc shares in Q1 2018, an estimated $227K.
Callahan Advisors first reported a position in Natus Medical Inc in Q3 2015 and held it in 10 quarters.
Callahan Advisors's Natus Medical Inc position peaked at $1.19M in Q4 2016.
184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on Callahan Advisors's 13F filing for Q1 2018, filed 30 Apr 2018.